MENU

Radiation Oncology Resident Research Publications and Presentations

Resident Research Publications 2013-2017

The following are publications in peer-reviewed journals or book chapters written by Fox Chase residents during their residency in the past 5 years on which they were the first authors:

2017

Churilla TM, Ballman KV, Brown PD, Twohy EL, Jaeckle K, Farace E, Cerhan JH, Anderson SK, Carrero XW, Garces YI, Barker FG, Deming R, Dixon JG, Burri SH, Chung C, Menard C, Stieber VW, Pollock BE, Galanis E, Buckner JC, Asher AL. Stereotactic radiosurgery with or without whole brain radiotherapy for limited brain metastases: a secondary analysis of the NCCTG N0574 (Alliance) randomized controlled trial. The International Journal of Radiation Oncology, Biology, Physics, 2017

Churilla TM, Handorf E, Collette S, Collette L, Dong Y, Aizer A, Kocher M, Soffietti R, Alexander BM, Weiss SE.  Whole brain radiotherapy after stereotactic radiosurgery or surgical resection among patients with 1-3 brain metastases and favorable prognoses: A secondary analysis of EORTC 22952-26001. Annals of Oncology, 2017.

Dong Y, Li T, Churilla TM, Shaikh T, Sigurdson ER, Bleicher RJ, Weiss SE, Hayes SB, Anderson PR "Impact of Rheumatoid Arthritis on Radiation-related Toxicity and Cosmesis in Breast Cancer Patients: A Contemporary Matched Pair Analysis" Breast Cancer Res Treat. 2017 Aug 19. doi: 10.1007/s10549-017-4438-7 (PMID 28825145)

Dong Y, Zaorsky NG, Li T, Churilla TM, Viterbo R, Sobczak ML, Smaldone MC, Chen DY, Uzzo RG, Hallman MH, Horwitz EM “Effects of interruptions of external beam radiation therapy for prostate cancer” Accepted to Journal of Medical Imaging and Radiation Oncology, Aug 2017

Dong Y, Stock-Martineau S, Soulières D, Galloway T Chapter “Therapies Targeting VEGF/Angiogenesis and Other Novel Agents for SCCHN” Head and Neck Cancers: Evidence-based Treatment, Demos Medical Publishing, LLC, New York, 2017

Dong Y, Churilla TM Chapter “Extremity sarcoma” Radiation Oncology Question-based Review, 3rd edition, Wolters Kluwer, 2017

Dong Y, Ridge JA, Li T, Lango MN, Churilla TM, Bauman JR, Galloway TJ “Long-term Toxicities in 10-year Survivors of Radiation Treatment for Head and Neck Cancer” Oral Oncol. 2017 Aug;71:122-128 (PMID: 28688679)

Dong Y, Ruth KJ, Churilla TM, Viterbo R, Sobczak ML, Smaldone MC, Chen DY, Uzzo RG, Hallman MH, Horwitz EM “The need for androgen deprivation therapy in patients with intermediate-risk prostate cancer treated with dose-escalated external beam radiation therapy” Can J Urol. 2017 Feb;24(1):8656-8662 (PMID: 28263132)

Shaikh T, Handorf EA, Meyer JE, Hall MJ, Esnaola NF. Mismatch Repair Deficiency Testing in Patients With Colorectal Cancer and Nonadherence to Testing Guidelines in Young Adults.JAMA Oncol. 2017 Nov 9:e173580. doi: 10.1001/jamaoncol.2017.3580. [Epub ahead of print] PMID: 29121143

Shaikh T, Meyer JE, Horwitz EM.  Optimal Use of Combined Modality Therapy in the Treatment of Esophageal Cancer.Surg Oncol Clin N Am. 2017 Jul;26(3):405-429. doi: 10.1016/j.soc.2017.01.009. Epub 2017 May 11. Review. PMID: 28576180

Shaikh T, Li T, Handorf EA, Johnson ME, Wang LS, Hallman MA, Greenberg RE, Price RA Jr, Uzzo RG, Ma C, Chen D, Geynisman DM, Pollack A, Horwitz EM.    Long-Term Patient-Reported Outcomes From a Phase 3 Randomized Prospective Trial of Conventional Versus Hypofractionated Radiation Therapy for Localized Prostate Cancer. Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):722-731. doi: 10.1016/j.ijrobp.2016.12.034. Epub 2016 Dec 28. PMID: 28244407

Zaorsky NG, Lee CT, Zhang E, Galloway TJ. Hypofractionated radiation therapy has favorable cosmesis for indolent skin cancers. Radiother Oncol. 2017.

Zaorsky NG, Showalter TN, Ezzel GA, Nguyen PL, Assimos DG, D’Amico AV, Gottschalk AR, Gustafson GS, Keole SR, Liauw SL, Lloyd S, McLauglin PW, Movsas B, Prestige BR, Taira AV, Vapiwala N, Davis BJ. ACR Appropriateness Criteria® external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II.   Adv Radiat Oncol. 2017

Zaorsky NG, Showalter TN, Ezzel GA, Nguyen PL, Assimos DG, D’Amico AV, Gottschalk AR, Gustafson GS, Keole SR, Liauw SL, Lloyd S, McLauglin PW, Movsas B, Prestige BR, Taira AV, Vapiwala N, Davis BJ. ACR Appropriateness Criteria® external beam radiation therapy treatment planning for clinically localized prostate cancer, part II of II.   Adv Radiat Oncol. 2017

Zaorsky NG, Davis BJ, Nguyen PL, Showalter TN, Hoskin PJ, Yoshioka T, Morton G, Horwitz EM. Evolution of brachytherapy for prostate cancer. Nat Rev Urol. 2017.

Zaorsky NG, Williams GR, Barta SK, Esnaola NF, Kropf P, Hayes SB, Meyer JE. Splenic irradiation for splenomegaly: a systematic review. Cancer Treat Rev. 2017. 22;53:47-52.

 

2016

Avkshtol V, Dong Y, Hayes SB, et al. A comparison of robotic arm versus gantry linear accelerator stereotactic body radiation therapy for prostate cancer. Res Rep Urol. 2016;8:145-58.

Churilla TM, Egleston B, Murphy C, Sigurdson E, Hayes S, Goldstein L, Bleicher R. Patterns of Multidisciplinary Care in the Management of Non-Metastatic Invasive Breast Cancer in the United States Medicare Patient. Breast Cancer Research and Treatment. 2016, Sep 17. DOI:10.1007/s10549-016-3982-x

Churilla TM, Egleston B, Dong Y, Shaikh, T, Murphy C, Mantia-Smaldone G,  Chu C, Rubin S, Anderson, P. “Disparities in the Management and Outcome of Cervical Cancer in the United States according to Health Insurance Status.”  Gynecologic Oncology.2016, Jun; 141(3) 516-23.  DOI:10.1016/j.ygyno.2016.03.025

Churilla TM, Egleston B, Murphy C, Sigurdson E, Hayes S, Goldstein L, Bleicher R. “Patterns of Multidisciplinary Care in the Management of Non-Metastatic Invasive Breast Cancer in the United States Medicare Patient.” Breast Cancer Research and Treatment. 2016, Sep 17. DOI:10.1007/s10549-016-3982-x

DongY, LiT, ChurillaTM, ViterboR, SobczakM, SmaldoneM, ChenD,  UzzoR, HallmanM, HorwitzEM,  “Effects of Time to Treatment on Biochemical and Clinical Outcomes for Patients with Prostate Cancer Treated with Definitive Radiation”,  Clin Genitourin Cancer. 2016 Oct;14(5):e463-e468. doi: 10.1016/j.clgc.2016.01.014. Epub 2016 Feb 10.

Leachman BK, Galloway TJ. Management of Sarcoma: The Role for Radiation Therapy. Surgical Clinics of North America (2016). 96(5), 1127-1139.

Murphy CT, Galloway TJ, Handorf EA, Egleston BL, Wang LS, Mehra R, Flieder DB, Ridge JA.  “Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States”. J Clin Oncol. 2016 Jan 10;34(2):169-78. doi: 10.1200/JCO.2015.61.5906.

Shaikh T, Handorf EA, Murphy CT, Mehra R, Ridge JA, Galloway TJ. “The impact of radiation treatment time on survival in patients with head and neck cancer.”  Int J Radiat Oncol Biol Phys. Accepted. Manuscript in Print.

Shaikh T, Churilla TM, Murphy CT, Zaorsky NG, Haber A, Hallman M, Meyer JE.  “Absence of pathological proof of cancer associated with improved outcomes in early stage lung cancer.” J Thorac Oncol. 2016 Apr 19. (PMID: 27109322)

Shaikh T, Churilla TM, Mantia-Smaldone GM, Chu C, Rubin SC, Anderson PR. “The role of adjuvant radiation in lymph node positive endometrial adenocarcinoma.” Gynecol Oncol. 2016 Apr 14. (PMID: 27090796)

Shaikh T, Churilla TM, Monpara P, Scott WJ, Cohen SJ, Meyer JE. “Risk of radiation pneumonitis in patients receiving taxane-based tri-modality therapy for locally advanced esophageal cancer.” Pract Radiat Oncol. 2016 Feb 27. (PMID: 27025161)

Shaikh T, Li T, Murphy CT, Zaorsky NZ, Bleicher RJ, Sigurdson ER, Carlson R, Hayes SB, Anderson PR. “Importance of surgical margin status in ductal carcinoma in situ.” Clin Breast Cancer. 2016 Feb 12. (PMID: 26952595)

Shaikh T, Wang LS, Ruth K, Hallman M, Chen DY, Greenberg RE, Li J, Crawford K, Horwitz EM. “Trainee involvement does not impact outcomes in low dose rate brachytherapy for prostate cancer.” Brachytherapy. 2016 Jan 29. (PMID: 26832675)

Wang LS, Murphy CT, Handorf EA, Freedman G, Johnson ME, Shaikh T, Hayes SB, Bleicher R, Goldstein L, Anderson PA. Long-term Toxicity and Outcomes of Hypofractionated Radiation Therapy With an Incorporated Boost for Early-Stage Breast Cancer. Manuscript in preparation.

Zaorsky NG, Churilla TM, Ruth K, Hayes SB, Sobczak ML, Hallman MA, Smaldone MC, Chen DYT, Horwitz EM. Men’s health supplement use and outcomes in men receiving definitive intensity-modulated radiation therapy for localized prostate cancer. Amer J Clin Nutr. 2016

Zaorsky NG, Churilla TM, Egleston BL, Fisher SG, Ridge JA, Horwitz EM, Meyer JE.  Causes of death among cancer patients.  Annals of Oncol. 2016.

Zaorsky NG, Ricco AG, Churilla TM, Horwitz EM, Den RB. ASTRO APEx® and RO-ILS™ are applicable to medical malpractice in radiation oncology. Future Oncol. 2016 Jul 29.

Zaorsky NG, Shaikh T, Murphy CT, Hallman MA, Hayes SB, Sobczak ML, Horwitz EM.  Comparison of outcomes and toxicities among radiation therapy treatment options for prostate cancer.  Cancer Treat Rev. 2016. 48:50-60.

Zaorsky NG, Showalter TN, Ezzel GA, Nguyen PL, Assimos DG, D’Amico AV, Gottschalk AR, Gustafson GS, Keole SR, Liauw SL, Lloyd S, McLauglin PW, Movsas B, Prestige BR, Taira AV, Vapiwala N, Davis BJ. External beam radiation therapy for clinically localized prostate cancer, part I of II: Target volumes and treatment planning.  Applied Rad Onc.  2016. (in press)

Zaorsky NG, Showalter TN, Ezzel GA, Nguyen PL, Assimos DG, D’Amico AV, Gottschalk AR, Gustafson GS, Keole SR, Liauw SL, Lloyd S, McLauglin PW, Movsas B, Prestige BR, Taira AV, Vapiwala N, Davis BJ. External beam radiation therapy for clinically localized prostate cancer, part II of II: Treatment delivery. Applied Rad Onc. 2016.

Zaorsky NG, Egleston BL, Horwitz EM, Dicker AP, Nguyen PL, Showalter TN, Den RB. The missing pieces in reporting of randomized controlled trials of external beam radiation therapy dose escalation for prostate cancer Am J Clin Oncol. 2016

Zaorsky NG, Keith SW, Shaikh T, Nguyen PL, Horwitz EM, Dicker AP, Den RB. Impact of Radiation Therapy Dose Escalation on Prostate Cancer Outcomes and Toxicities. Am J Clin Oncol. 2016 Mar 24

Zaorsky NG, Wang HH, Cui YL, Lan J, Deng L, Zeng XL, Wu ZQ, Tao Z, Guo WH, Wang QX, Zhao LJ, Yuan ZY, Lu Y, Wang P, Meng MB.  Mesenchymal stem cells generate pericytes to promote tumor recurrence via vasculogenesis after stereotactic body radiation therapy. Cancer Lett. 2016 Mar 17. pii: S0304-3835(16)30101-X. doi: 10.1016/j.canlet.2016.02.033.

Zaorsky NG, Horwitz EM. Brachytherapy for prostate cancer (Chapter). In: Prostate Cancer: Science and Clinical Practice. 2016. Mydlo JH, Godec CJ (Eds.). 399-412. ISBN: 9780128000779.

Zaorsky NG, Ruth K, Shaikh T, Smaldone MC, Hallman MA, Slifker M, Viterbo R, Chen DY, Hayes, SB, Sobczak ML, Horwitz EM. Prostate Cancer Patients With Unmanaged Diabetes or Receiving Insulin Experience Inferior Outcomes and Toxicities After Treatment With Radiation Therapy.  Clin Genitourinary Cancer. 2016.

Zaorsky NG, Williams GR, Barta SK, Esnaola NF, Kropf P, Hayes SB, Meyer JE. Splenic irradiation for splenomegaly: a systematic review. Cancer Treat Rev. 2016.

2015

... Expand

Resident Meeting Presentations 2013-2017

During their training, residents are also encouraged and provided funding to present their papers at major national meetings.  These recent residents have been first author presenters of scientific abstracts as poster, poster presentations, or oral presentations during the past 5 years:

2017

Avkshtol, V., et al. “Peripheral Blood Lymphocyte Gamma-H2AX as a Predictor for Treatment Response in Rectal Cancer Patients.” International Journal of Radiation Oncology*Biology*Physics, vol. 99, no. 2, 2017, doi:10.1016/j.ijrobp.2017.06.1988.

Churilla TM, Chowdhury I, Handorf E, Collette L, Collette S, Alexander B, Kocher M, Soffietti R, Claus E, Weiss SE. Comparison of local control of brain metastasis with stereotactic radiosurgery versus surgical resection: A secondary analysis of EORTC 22952-26001. 2017 RSS Annual Scientific Meeting, Las Vegas, NV, 2017.

Churilla TM, Chowdhury I, Handorf E, Collette L, Collette S, Dong Y, Alexander B, Kocher M, Soffietti R, Claus E, Weiss SE. Comparison of local control of brain metastasis with stereotactic radiosurgery versus surgical resection: A secondary analysis of EORTC 22952-26001. 59th Annual ASTRO Conference, San Diego CA, 2017.

Churilla TM, DeMora L, Handorf E, Zaorsky N, Dong Y, Denlinger C, Sigurdson E, Meyer JE. Are early stage anal cancer patients over-treated with chemoradiotherapy? ARS 99th Annual Meeting, Colorado Springs, CO, 2017.

Dong Y, Li T, Churilla TM, Shaikh T, Sigurdson ER, Bleicher RJ, Weiss SE, Hayes SB, Anderson PR "Impact of Rheumatoid Arthritis on Radiation-related Toxicity and Cosmesis in Breast Cancer Patients: A Contemporary Matched Pair Analysis" ASTRO Annual Meeting 2017, San Diego, CA

Dong Y, Egleston B, Price RA, Rosenstein BS, Meyer JE “The history of the Lyman-Kutcher-Burman model and its application to the alpha-beta ratio modeling using modern statistics” ASTRO Annual Meeting 2017, San Diego, CA

Leachman BK, DeMora L, Churilla TM, Bauman J, Lango MN, Egleston B, Galloway TJ. Patterns of Initial Therapy for Larynx Cancer in Elderly Patients: A Population Based Analysis. Poster presented September 2017 at ASTRO’s Annual Meeting, San Diego, CA.

Leachman BK, Sharf LJ, Sobczak ML. Colorectal Cancer Screening Among Men with Newly Diagnosed Prostate Cancer. Oral Presentation May 2017 at American Radium Society Annual Meeting, Colorado Springs, CO.

Lee D, Li T, Hallman MA, Chen D, Dong Y, Leachman BK, Veltchev I, Greenberg R, Sobczak ML, Horwitz EM.  Comparison of Toxicities in High Dose Rate vs Low Dose Rate Brachytherapy as Monotherapy in patients with Low and Favorable Intermediate Risk Prostate Cancer.  Poster presentation at 59th Annual ASTRO Conference, San Diego CA, 2017

Wong JK, DeMora L, Shaikh T, Borghaei H, Meyer JE, Hallman MA. Identifying predictors of distant relapse following SBRT for stage I NSCLC: Is there a role for systemic therapy? Poster presentation at 59th Annual ASTRO Conference, San Diego, CA, 2017.

Wong JK, DeMora L, Shaikh T, Borghaei H, Meyer JE, Hallman MA. An Analysis of Salvage Treatment Pattern following SBRT for Stage I NSCLC and Impact on Overall Survival. Poster Presentation at 2017 Radiosurgical Society Meeting, Las Vegas, NV, 2017.

Zaorsky NG, Ahmed A, Yoon S, Fuller CD, Thomas CR Jr, Choi M, Holliday EB. Financial Conflicts of Interest Are Correlated With Publication Productivity Among Academic Radiation Oncologists. RSNA. (Oral and poster)

Zaorsky NG. Radiation therapy treatment options for prostate cancer.  Penn State College of Medicine – Department of Urology Lecture. 2017.10.18. (Oral presentation)

Zaorsky NG. The evolution of radiation therapy for prostate cancer. Penn State Cancer Institute Grand Rounds. 2017.08.10. (Oral presentation)

Zhang E, Ruth KJ, Buyyounouski MK, Price 3rd RA, Uzzo RG, Sobczak ML, Pollack A, White T, Wong JK, Chen DYT, Hallman MA, Greenberg RE, Watkins-Bruner D, Al-Saleem T, Horwitz EM. Long Term Results of a Phase III Randomized Prospective Trial of Erectile Tissue Sparing IMRT for Men with Clinically Localized Prostate Cancer. Oral presentation at the 2017 American Society for Radiation Oncology (ASTRO) Annual Meeting.

Zaorsky NG, Davis BJ, Nguyen PL, Showalter TN, Hoskin PJ, Yoshioka T, Morton G, Horwitz EM. Evolution of brachytherapy for prostate cancer. ARS. 2017. (Abstract, poster presentation)

Zaorsky NG, Williams GR, Barta SK, Esnaola NF, Kropf P, Hayes SB, Meyer JE. Splenic irradiation for splenomegaly: a systematic review. ARS. 2017. (Abstract, poster presentation)

Zaorsky NG, Lee CT, Zhang E, Galloway TJ. Hypofractionated radiation therapy has favorable cosmesis for indolent skin cancers. ARS. 2017. (Abstract, poster presentation)

Zaorsky NG, Trifiletti DM. Evaluating a practice in radiation oncology. ARRO. 2017.

Zaorsky NG, Williams GR, Barta SK, Esnaola NF, Kropf P, Hayes SB, Meyer JE. Splenic irradiation for splenomegaly: a meta-analysis. ACRO. 2017 March (Abstract, travel award)

 

2016

Avkshtol, V., Doss, M., Devarajan, K., Eastwick, G., Cohen, S., Cooper, H., Meyer, J. “Using Metabolic Tumor Velocity to Preoperatively Predict the Neoadjuvant Rectal Score.” International Journal of Radiation Oncology*Biology*Physics, vol. 96, no. 2, 2016, doi:10.1016/j.ijrobp.2016.06.1110.

Churilla TM, Handorf E, Soffietti R, Kocher M, Aizer A, Collette L, Collette S, Dong Y, Weiss SE. Does whole brain radiotherapy for oligometastatic brain metastases translate into a survival benefit for patients with a limited competing risk from extra-cranial disease? A secondary analysis of EORTC 22952-26001. 58th Annual ASTRO Conference, Boston, MA, 2016.  

Churilla TM, Egleston B, Dong Y, Lango M, Galloway T. The Impact of Health Insurance Status on the Presentation, Local Management, and Outcomes of Patients with Head and Neck Cancer in the United State. 2016 Multidisciplinary Head and Neck Symposium, Phoenix, Arizona, 2016.

DongY, LiT,  ChurillaTM,  ViterboR, SobczakM, SmaldoneM,  ChenD, UzzoR, HallmanM, HorwitzEM,  Effects of Protraction of Radiotherapy on Outcomes of Patients with Prostate Cancer ASCO GU Meeting, Jan 7-9, 2016, San Francisco 

Leachman BK, Shaikh TA, Li T, Anderson PR. Association between Body Mass Index and Treatment Outcomes in Women Undergoing Breast Conservation: An Analysis of 3850 Women. Poster presented September 2016 at ASTRO’s 58th Annual Meeting, Boston, MA.

Leachman BK, Shaikh TA, Chu CS, Rubin SC, Anderson PR. Addition of brachytherapy to adjuvant external beam radiation in patients with cervical cancer. Poster presented June 2016 at the World Congress of Brachytherapy, San Francisco, CA.

Murphy CT, Handorf E, Sigurdson ER, Hayes SB, Anderson PR, Weiss S, Shaikh T, Daly JM, Boraas M, Bleicher RJ. “Assessment of National Practice Patterns of Radiation Therapy Use after Neoadjuvant Chemotherapy for Breast Cancer.” (Poster Presentation at ASTRO Annual Meeting 2016)

Shaikh T, Ruth K, Devarajan K, Zaorsky NG, Hallman MA, Sobczak M, Chen D, Uzzo R, Smaldone M, Kutikov A, Greenberg R, Viterbo R, Pollack A, Horwitz EM. “Dosimetric and clinical predictors of long term toxicity in patients undergoing hypofractionated prostate radiotherapy: results from a randomized phase III trial.” (Oral Presentation at ASTRO Annual Meeting 2016)

Shaikh T, Churilla TM, Murphy CT, Zaorsky NG, Haber A, Hallman M, Meyer JE. “Over treatment of clinically diagnosed early stage lung cancer.” (Oral Presentation at ESMO European Lung Cancer Conference 2016)

Shaikh T, Churilla TM, Murphy CT, Hall MJ, Sigurdson ER, Meyer JE. “The Role of Adjuvant Radiotherapy in T4 Colon Cancer.” (Oral Presentation at ARS Annual Meeting 2016)

Shaikh T, Churilla TM, Murphy CT, Hallman MA, Scott WJ, Meyer JE. “Comparative effectiveness of lobectomy, sublobar resection, and stereotactic body radiotherapy for clinical stage I non-small cell lung cancer: a propensity-matched analysis.” (Poster Presentation at ASTRO Annual Meeting 2016)

Shaikh T, Churilla TM, Zaorsky NG, Murphy CT, Carlson R, Weiss S, Anderson, PR, Hayes SB. “Post-mastectomy radiotherapy in women with ypN0-N3 breast cancer.” (Poster Presentation at ASTRO Annual Meeting 2016)

Shaikh T, Churilla TM, Mantia-Smaldone GM, Chu C, Rubin SC, Anderson PR. “The role of adjuvant radiation in lymph node positive endometrial adenocarcinoma.” (Featured Poster Presentation at Society of Gynecologic Oncology Annual Meeting 2016)

Shaikh T, Handorf E, Murphy CT, Mehra R, Ridge JA, Galloway TJ. “The impact of chemoradiation treatment time on survival in patients with head and neck cancer.” (Poster Presentation at Multidisciplinary Head and Neck Cancer Symposium 2016)

Shaikh T, Ruth K, Zaorsky NG, Hallman MA, Geynisman DM, Kutikov A, Smaldone MC, Chen DY, Sobczak M, Horwitz EM. “Comparative effectiveness of intensity modulated radiation therapy versus three-dimensional conformal radiation for localized prostate cancer.” (Poster Presentation at ASCO Genitourinary Cancers Symposium 2016)

Zaorsky NG, Churilla TM, Egleston BL, Fisher SG, Ridge JA, Horwitz EM, Meyer JE.   Causes of death among cancer patients as a function of calendar year, age, and time after diagnosis.  ESMO. 2016 October 5. (Abstract, poster presentation)

Zaorsky NG. Evolution of radiation therapy for prostate cancer.  2016 October 4. North Estonia Medical Centre.  Tallinn, Estonia. (Oral presentation)

Zaorsky NG. Evolution of radiation therapy for prostate cancer.  2016 October 11. University of Copenhaven - Herlev Hospital.  Copenhagen, Denmark (Oral presentation)

Zaorsky NG, Ricco A, Churilla TM, Horwitz EM, Den RB. Applying ASTRO APEx Guidelines and RO-ILS to Medical Malpractice in Radiation Oncology. ASTRO 2016.  2016 October. Boston, MA, USA. (Abstract, poster presentation)

Zaorsky NG, Handorf E, Horwitz EM, Hallman MA, Smaldone MC.  Pretreatment Predictors of Receiving Adjuvant Radiation Therapy for Prostate Cancer. ASTRO 2016.  2016 October. Boston, MA, USA. (Abstract, poster presentation)

Zaorsky NG, Ricco AG, Churilla TM, Horwitz EM, Den RB. Medical malpractice in radiation oncology.  ARS 2016. Philadelphia, PA (Oral presentation, abstract)

Zaorsky NG, Churilla TM, Egleston BL, Fisher SG, Ridge JA, Horwitz EM, Meyer JE.   Risk of death among cancer patients.  ARS 2016. April. (Abstract, poster presentation)

 

2015

... Expand

Connect with Fox Chase